Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP
NCT00565370
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Advanced Gastric Cancer
Interventions
DRUG:
Capecitabine, Cisplatin, Sorafenib
Sponsor
Asan Medical Center